Orlistat: A Viewpoint by Priscilla A. Hollander

Hollander, P.A.
November 2001
Drugs;Nov2001, Vol. 61 Issue 14, p2120
Academic Journal
Comments on the effectiveness of orlistat, a pancreatic lipase inhibitor which has been shown to be an effective antiobesity drug by decreasing fat uptake in the gut. Impact on weight loss and long-term weight maintenance; Adverse effects; Role in achieving glucose control in obese patients thereby preventing diabetes.


Related Articles

  • 36 year old man presenting with pancreatitis and a history of recent commencement of orlistat case report. Napier, Sarah; Thomas, Matthew // Nutrition Journal;2006, Vol. 5, p19 

    Background: Orlistat is an anti-obesity drug licensed in the United Kingdom for 7 years. We present a case of a patient who developed pancreatitis four days after commencing orlistat. Case presentation: A 36 year old man presented to hospital with acute severe pancreatitis four days after...

  • Combined Pharmacologic/Nonpharmacologic Intervention in Individuals at High Risk of Developing Type 2 Diabetes. Garber, Alan J. // Diabetes Care;Nov2009 Supplement, Vol. 32, pS184 

    The article focuses the effectiveness of combined pharmacologic and lifestyle changes in type 2 diabetes prevention among high-risk individuals based on several studies. The author questions the correlation of diet and exercise with glucose tolerance improvement because patients have difficulty...

  • Chapter 3: Is There Anything That Changes How My Body Deals with Fat? Hunter, William // When Dieting Isn't Enough: Medications & Surgeries for Weight Lo;2005, p39 

    This article provides information on the obesity drug Xenical®, which changes how the body absorbs fat. The human body has a very specific way of digesting and absorbing fats. Each organ of the digestive system is specialized to deal with one or possibly two nutrient types. Xenical prevents...

  • Flushing away the fat. Garrow, John // BMJ: British Medical Journal (International Edition);09/26/98, Vol. 317 Issue 7162, p830 

    Examines the problem of obesity throughout the world, with emphasis on the launch of `orlistat' as a prescription inhibitor of pancreatic lipase. How obesity is viewed by the World Health Organization; Reference to a 1980 survey conducted in the United Kingdom in relation to obesity;...

  • Obesity Drug Inhibits Prostate Tumor Growth.  // Ascribe Newswire: Medicine;3/22/2004, p41 

    The Burnham Institute's Jeffrey Smith, has discovered that orlistat, commonly prescribed as an anti-obesity drug orlistat, marketed as XenicalT, has a positive side-effect: it inhibits cancer growth. Smith made this discovery using an activity-based proteomics screening technique developed in...

  • Evaluation of Safety and Anti-obese Activity of a Polyherbal Formulation -- Simlim Capsule. Shah, Bijal N.; Soni, Hardik K.; Patel, Ghanshyam R.; Patel, Pooja D.; Paranjape, Archana N. // International Journal of Pharmaceutical & Phytopharmacological R; 

    Obesity is one the most common and now considered as global health problem which triggers many other metabolic disorders. In the present study, a polyherbal formulation - Simlim Capsule was evaluated for its anti-obesity activity in high fat diet (HFD) induced male Wistar albino rats. It was...

  • NUTRITION.  // MPR - Residents' Edition;Fall/Winter2010, Vol. 19 Issue 2, p174 

    The article offers information on several approved nutritional supplements. Feosol, an iron supplement from GlaxoSmithKline, is used in alleviating iron deficiency and anemia. Xenical, a lipase inhibitor from Roche, is used as an aid in reducing calorie intake. Megace Oral Suspension from...

  • Xenical. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p809 

    An encyclopedia entry for "Xenical" is presented. It refers to a brand name of a drug pharmacologically called orlistat. The drug Xenical is commonly used for the treatment of patients who are exhibiting symptoms of mild to moderate obesity and more on those who are already on the stage of...

  • The New Diabetes Epidemic: What's Fueling It, How To Combat It.  // Environmental Nutrition;May2001, Vol. 24 Issue 5, p1 

    Provides tips on preventing type two diabetes in the United States. Link between obesity and diabetes; Complications of diabetes; Maintenance a health weight among diabetics; Necessity of physical activity; Monitor of blood sugar.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics